Options
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls
ISSN
1460-2083
0964-6906
Date Issued
2012
Author(s)
Timofeeva, Maria N.
Hung, Rayjean J.
Rafnar, Thorunn
Christiani, David C.
Field, John K.
Risch, Angela
McKay, James D.
Wang, Y.
Dai, Juncheng
Gaborieau, Valerie
McLaughlin, John R.
Brenner, Darren
Narod, Steven A.
Caporaso, Neil E.
Albanes, Demetrius
Thun, Michael
Eisen, Timothy
Wichmann, Heinz-Erich
Han, Younghun
Chen, Wei
Zhu, D.
Spitz, Margaret R.
Wu, X.
Pande, Mala
Zhao, Yang
Zaridze, David
Szeszenia-Dabrowska, Neonilia
Lissowska, Jolanta
Rudnai, Peter
Fabianova, Eleonora
Mates, Dana
Bencko, Vladimir
Foretova, Lenka
Janout, Vladimir
Krokan, Hans E.
Gabrielsen, Maiken Elvestad
Skorpen, Frank
Vatten, Lars
Njolstad, Inger
Chen, Chu
Goodman, Gary
Lathrop, Mark
Benhamou, Simone
Vooder, Tonu
Vaelk, Kristjan
Nelis, Mari
Metspalu, Andres
Raji, Olaide Y.
Chen, Ying
Gosney, John
Liloglou, Triantafillos
Muley, Thomas
Dienemann, Hendrik
Thorleifsson, Gudmar
Shen, Hongbing
Stefansson, Kari
Brennan, P. C.
Amos, Christopher I.
Houlston, Richard S.
Landi, Maria Teresa
DOI
10.1093/hmg/dds334
Abstract
Recent genome-wide association studies (GWASs) have identified common genetic variants at 5p15.33, 6p216p22 and 15q25.1 associated with lung cancer risk. Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses. To identify novel risk variants for lung cancer, we performed a meta-analysis of 16 GWASs, totaling 14 900 cases and 29 485 controls of European descent. Our data provided increased support for previously identified risk loci at 5p15 (P 7.2 10(16)), 6p21 (P 2.3 10(14)) and 15q25 (P 2.2 10(63)). Furthermore, we demonstrated histology-specific effects for 5p15, 6p21 and 12p13 loci but not for the 15q25 region. Subgroup analysis also identified a novel disease locus for squamous cell carcinoma at 9p21 (CDKN2A/p16(INK4A)/p14(ARF)/CDKN2B/p15(INK4B)/ANRIL; rs1333040, P 3.0 10(7)) which was replicated in a series of 5415 Han Chinese (P 0.03; combined analysis, P 2.3 10(8)). This large analysis provides additional evidence for the role of inherited genetic susceptibility to lung cancer and insight into biological differences in the development of the different histological types of lung cancer.